| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX005 (ip) | mean tumor weight | other | 6.25 mg/kg/injection | 49.0 | Antitumor endpoint evaluated on day 16; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean tumor weight | other | 12.5 mg/kg/injection | 70.0 | Antitumor endpoint evaluated on day 16; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean tumor weight | other | 25.0 mg/kg/injection | 65.0 | Antitumor endpoint evaluated on day 16; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean tumor weight | other | 50.0 mg/kg/injection | 47.0 | Antitumor endpoint evaluated on day 16; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean tumor weight | other | 100.0 mg/kg/injection | 41.0 | Antitumor endpoint evaluated on day 16; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 6.25 mg/kg/injection | 19.0 | Antitumor endpoint evaluated on day 14; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 6.25 mg/kg/injection | 21.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 6.25 mg/kg/injection | 30.0 | Antitumor endpoint evaluated on day 14; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 12.5 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 14; 05/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 12.5 mg/kg/injection | 32.0 | Antitumor endpoint evaluated on day 14; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 25.0 mg/kg/injection | 14.0 | Antitumor endpoint evaluated on day 14; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 25.0 mg/kg/injection | 3.0 | Antitumor endpoint evaluated on day 14; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 50.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 14; 00/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 50.0 mg/kg/injection | 21.0 | Antitumor endpoint evaluated on day 14; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 100.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 14; 00/10 animals surviving on tox evaluation day (usually day 5) |